Cargando…

Construction of CTLA-4-Ig Fusion Gene in pBudCE4.1 Expression Vector

BACKGROUND: CTLA-4 inhibitory signals prevent cell cycle progression and IL-2 production, leading to a halt on an ongoing immune response. CTLA4-Ig fusion proteins contain the extracellular domain of CTLA-4 and Fc fragment of human IgG antibody. In this study we aimed to fuse the ctla-4 gene encodin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazdanpanah-Samani, Mahsa, Mahmoudi Maymand, Elham, Jahangeerfam, Tayebeh, Ghaderi, Abbas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Research Institute 2015
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629461/ https://www.ncbi.nlm.nih.gov/pubmed/26605013

Ejemplares similares

Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities
por: Kaviani, Elina, et al.
Publicado: (2022)

Killer Cell Immunoglobulin-Like Receptors (KIRs) Genotype and Haplotype Analysis in Iranians with Non-Melanoma Skin Cancers
por: Yousefinejad, Fahimeh, et al.
Publicado: (2019)

Effects of CTLA4-Ig on human monocytes
por: Tono, Toshihiro, et al.
Publicado: (2017)

Blood PD-1(+)TFh and CTLA-4(+)CD4(+) T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis
por: Aldridge, Jonathan, et al.
Publicado: (2021)

Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig
por: Rochman, Yrina, et al.
Publicado: (2015)

CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
por: Cross, A.H., et al.
Publicado: (1994)

CTLA-4Ig Improves Hyperalgesia in a Mouse Model of Osteoporosis
por: Nagao, Nobuto, et al.
Publicado: (2020)

A Novel Therapeutic Effect of a New Variant of CTLA4-Ig with Four Antennas That Are Terminally Capped with Sialic Acid in the CTLA4 Region
por: Piao, Yongwei, et al.
Publicado: (2022)

CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk
por: Mayer, Edda, et al.
Publicado: (2013)

Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector
por: Rim, Yeri Alice, et al.
Publicado: (2014)

Functional Characteristics of C-terminal Lysine to Cysteine Mutant Form of CTLA-4Ig
por: Kim, Bongi, et al.
Publicado: (2013)

Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice
por: Young, James S., et al.
Publicado: (2017)

Probing the mechanical properties of ORF3a protein, a transmembrane channel of SARS-CoV-2 virus: Molecular dynamics study
por: Maymand, Vahid Mahmoudi, et al.
Publicado: (2023)

Development of an intravital imaging system for the synovial tissue reveals the dynamics of CTLA-4 Ig in vivo
por: Hasegawa, Tetsuo, et al.
Publicado: (2020)

Effect of CTLA4-Ig on Obliterative Bronchiolitis in a Mouse Intrapulmonary Tracheal Transplantation Model
por: Suzuki, Yamato, et al.
Publicado: (2021)

Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection
por: Iglesias, Marcos, et al.
Publicado: (2022)

Cloning and identification of the CTLA-4IgV gene and functional application of vaccine in Xinjiang sheep
por: Kong, Huifang, et al.
Publicado: (2022)

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms
por: Berry, Andrew, et al.
Publicado: (2008)

CTLA-4: From conflict to clinic
por: Bashyam, Hema
Publicado: (2007)

The role of CTLA-4 in immune regulation
por: Verhagen, Johan, et al.
Publicado: (2008)

Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice
por: Na, Manli, et al.
Publicado: (2017)

Structure Prediction and Expression of Modified rCTLA4-Ig as a Blocker for B7 Molecules
por: Mahdizadeh, Hossein, et al.
Publicado: (2020)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023)

HTML 4.1 /
por: Galeano Gil, Germán
Publicado: (2006)

Identification and Quality Assessment of Chrysanthemum Buds by CE Fingerprinting
por: Xing, Xiaoping, et al.
Publicado: (2015)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CTLA-4 Insufficiency due to a Novel CTLA-4 Deletion, Identified through Copy Number Variation Analysis
por: Olfe, Lisa, et al.
Publicado: (2022)

Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
por: Rojas‑Restrepo, Jessica, et al.
Publicado: (2023)

Association of the CTLA-4 1722TC polymorphism and systemic lupus erythematosus: a systematic review and meta analysis
por: Shojaa, Mahdieh, et al.
Publicado: (2014)

Transplant-tolerance induction by CTLA-4Ig in liver-transplanted rats: a lesson for the treatment of autoimmune diseases?
por: Fischer, U, et al.
Publicado: (2003)

Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
por: Westhovens, R, et al.
Publicado: (2004)

CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production
por: Cutolo, Maurizio, et al.
Publicado: (2009)

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
por: Pieper, Jennifer, et al.
Publicado: (2013)

CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro
por: Pilat, Nina, et al.
Publicado: (2018)

A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis
por: Jiang, Fu-Yao, et al.
Publicado: (2023)

CTLA4 polymorphism and primary Sjögren's syndrome
por: Lester, Susan, et al.
Publicado: (2007)

CTLA-4 based therapy (MDX-010)
por: Korman, A
Publicado: (2003)

CTLA-4 and Autoimmunity: New Twists in the Tale
por: Walker, Lucy S.K.
Publicado: (2015)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fe106ppgvsb7n3som8flutde7j